| |
| |
|
| Insider
Information: |
Daniell Richard |
| Relationship: |
|
| City: |
Petach Tikva |
| State: |
L3 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
98,943 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,642,454 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
98,943 |
|
|
| Total
Value |
$1,642,454 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Teva Pharmaceutical Industries L... |
TEVA |
|
2024-03-05 |
98,943 |
2018-03-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
59 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TEVA |
Teva Pharmaceutical Indus... |
Exec. VP, European Commercial |
• – – |
2024-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,599 |
90,369 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Exec. VP, European Commercial |
• – – |
2023-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
70,840 |
93,424 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Exec. VP, European Commercial |
• – – |
2024-03-05 |
4 |
AS |
$13.52 |
$657,240 |
D/D |
(48,629) |
98,943 |
0 |
% |
|
| TEVA |
Teva Pharmaceutical Indus... |
Exec. VP, European Commercial |
• – – |
2024-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
33,512 |
103,282 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Exec. VP, European Commercial |
• – – |
2023-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
49,433 |
119,203 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Exec. VP, European Commercial |
• – – |
2023-03-06 |
4 |
AS |
$9.93 |
$178,776 |
D/D |
(18,002) |
123,777 |
0 |
% |
|
| TEVA |
Teva Pharmaceutical Indus... |
Exec. VP, European Commercial |
• – – |
2024-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
77,802 |
124,996 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Exec. VP, European Commercial |
• – – |
2024-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
62,250 |
132,020 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Exec. VP, European Commercial |
• – – |
2023-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
22,576 |
141,779 |
0 |
- |
|
59 Records found
|
|
Page 3 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
